1,395
Views
155
CrossRef citations to date
0
Altmetric
Reviews

Thiazolidinedione safety

, MD & , MD
Pages 565-579 | Published online: 22 May 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (11)

Amandeep Singh, Manik Aggarwal, Rajat Garg, Tyler Stevens & Prabhleen Chahal. (2022) Post-pancreatitis diabetes mellitus: insight on optimal management with nutrition and lifestyle approaches. Annals of Medicine 54:1, pages 1776-1786.
Read now
Carlos Antonio Trindade da Silva, Juliana Trindade Clemente-Napimoga, Henrique Ballassini Abdalla, Rosanna Tarkany Basting & Marcelo Henrique Napimoga. (2022) Peroxisome proliferator-activated receptor-gamma (PPARγ) and its immunomodulation function: current understanding and future therapeutic implications. Expert Review of Clinical Pharmacology 15:3, pages 295-303.
Read now
Diogo Turiani Hourneaux De Moura & Christopher C. Thompson. (2019) Endoscopic management of weight regain following Roux-en-Y gastric bypass. Expert Review of Endocrinology & Metabolism 14:2, pages 97-110.
Read now
Yoojin Noh, Sukhyang Lee & Sooyoung Shin. (2018) Durability of initial antidiabetic monotherapy and subsequent treatment adjustment patterns among newly treated type 2 diabetes patients. Therapeutics and Clinical Risk Management 14, pages 1563-1571.
Read now
Marco Tuccori, Irma Convertino, Maria Teresa Galiulo, Alessandra Marino, Alice Capogrosso-Sansone & Corrado Blandizzi. (2017) Diabetes drugs and the incidence of solid cancers: a survey of the current evidence. Expert Opinion on Drug Safety 16:10, pages 1133-1148.
Read now
Sooyoung Shin & Hyunah Kim. (2016) The effect of sitagliptin on cardiovascular risk profile in Korean patients with type 2 diabetes mellitus: a retrospective cohort study. Therapeutics and Clinical Risk Management 12, pages 435-444.
Read now
Jana Makuc. (2016) Management of pancreatogenic diabetes: challenges and solutions. Diabetes, Metabolic Syndrome and Obesity 9, pages 311-315.
Read now
Ye-Fong Du, Horng-Yih Ou, Elizabeth A Beverly & Ching-Ju Chiu. (2014) Achieving glycemic control in elderly patients with type 2 diabetes: a critical comparison of current options. Clinical Interventions in Aging 9, pages 1963-1980.
Read now
M Loredana Marcovecchio & Francesco Chiarelli. (2014) An update on the pharmacotherapy options for pediatric diabetes. Expert Opinion on Biological Therapy 14:3, pages 355-364.
Read now
Cong Zou & Honglin Hu. (2013) Use of pioglitazone in the treatment of diabetes: effect on cardiovascular risk. Vascular Health and Risk Management 9, pages 429-433.
Read now

Articles from other publishers (144)

Qing Zhang, Cheng-Xun He, Ling-Yu Wang, Die Qian, Dan-Dan Tang, Sheng-Nan Jiang, Wen-Wen Chen, Chun-Jie Wu & Wei Peng. (2023) Hydroxy-α-sanshool from the fruits of Zanthoxylum bungeanum Maxim. promotes browning of white fat by activating TRPV1 to induce PPAR-γ deacetylation. Phytomedicine 121, pages 155113.
Crossref
Lexiang Yu, Yuen Gao, Nicole Aaron & Li Qiang. (2023) A glimpse of the connection between PPARγ and macrophage. Frontiers in Pharmacology 14.
Crossref
Manish Manrai, Anupam K Singh, Chhagan Lal Birda, Jimil Shah, Aditya Dutta, Sanjay Kumar Bhadada & Rakesh Kochhar. (2023) Diabetes mellitus as a consequence of acute severe pancreatitis: Unraveling the mystery. World Journal of Diabetes 14:8, pages 1212-1225.
Crossref
Leonardo de Andrade Mesquita, Laura Fink Wayerbacher, Gilberto Schwartsmann & Fernando Gerchman. (2023) Obesity, diabetes, and cancer: epidemiology, pathophysiology, and potential interventions. Archives of Endocrinology and Metabolism 67:6.
Crossref
Jonas Groner, Martina Tognazzi, Melanie Walter, Daniel Fleischmann, Raphael Mietzner, Christian E. Ziegler, Achim M. Goepferich & Miriam Breunig. (2023) Encapsulation of Pioglitazone into Polymer–Nanoparticles for Potential Treatment of Atherosclerotic Diseases. ACS Applied Bio Materials 6:6, pages 2111-2121.
Crossref
Hagar A. Morgaan, Marwa Y. Sallam, Hanan M. El-Gowelli, Sahar M. El-Gowilly & Mahmoud M. El-Mas. (2023) Preeclamptic programming unevenly perturbs inflammatory and renal vasodilatory outcomes of endotoxemia in rat offspring: modulation by losartan and pioglitazone. Frontiers in Pharmacology 14.
Crossref
Qiuping Li, Hongying Zhang, Xinpeng Yan, Zhengxiao Zhao, Jian Qiu, Lingli Hu, Shan Jiang, Qing kong, Jing Sun & Lulu Li. (2023) Up-regulation of PPAR-γ involved in the therapeutic effect of icariin on cigarette smoke-induced inflammation. Pulmonary Pharmacology & Therapeutics 79, pages 102197.
Crossref
Enrica Flori, Sarah Mosca, Giorgia Cardinali, Stefania Briganti, Monica Ottaviani, Daniela Kovacs, Isabella Manni, Mauro Truglio, Arianna Mastrofrancesco, Marco Zaccarini, Carlo Cota, Giulia Piaggio & Mauro Picardo. (2023) The Activation of PPARγ by (2Z,4E,6E)-2-methoxyocta-2,4,6-trienoic Acid Counteracts the Epithelial–Mesenchymal Transition Process in Skin Carcinogenesis. Cells 12:7, pages 1007.
Crossref
Fu-Shun Yen, James Cheng-Chung Wei, Yu-Tung Hung, Chung Y. Hsu, Chii-Min Hwu & Chih-Cheng Hsu. (2023) Thiazolidinediones lower the risk of pneumonia in patients with type 2 diabetes. Frontiers in Microbiology 14.
Crossref
Jiang Li, Shaofeng Xu, Ling Wang & Xiaoliang Wang. (2023) PHPB Attenuated Cognitive Impairment in Type 2 Diabetic KK-Ay Mice by Modulating SIRT1/Insulin Signaling Pathway and Inhibiting Generation of AGEs. Pharmaceuticals 16:2, pages 305.
Crossref
Lingling Wang, Jiawei Wang, Mengjie Ma, Liping Shen, Tao Huang, Chunyue Huang, An Jia & Xiao Hu. (2022) Prenylated flavonoids from Morus nigra and their insulin sensitizing activity. Phytochemistry 203, pages 113398.
Crossref
Iris A. Leijten-van de Gevel, Kim H.N. van Herk, Rens M.J.M. de Vries, Nicolaas J. Ottenheym, Christian Ottmann & Luc Brunsveld. (2022) Indazole MRL-871 interacts with PPARγ via a binding mode that induces partial agonism. Bioorganic & Medicinal Chemistry 68, pages 116877.
Crossref
Yi-ni Cao, Shan-shan Yue, An-yi Wang, Lu Xu, Yi-tong Hu, Xue Qiao, Tung-Ying Wu, Min Ye, Yang-Chang Wu & Rong Qi. (2022) Antrodia cinnamomea and its compound dehydroeburicoic acid attenuate nonalcoholic fatty liver disease by upregulating ALDH2 activity. Journal of Ethnopharmacology 292, pages 115146.
Crossref
Gavin O’Mahony, Jens Petersen, Margareta Ek, Rebecca Rae, Carina Johansson, Liu Jianming, Nina Prokoph, Fredrik Bergström, Krister Bamberg, Fabrizio Giordanetto, Bader Zarrouki, Daniel Karlsson & Anders Hogner. (2022) Discovery by Virtual Screening of an Inhibitor of CDK5-Mediated PPARγ Phosphorylation. ACS Medicinal Chemistry Letters 13:4, pages 681-686.
Crossref
Gaofeng Yuan. 2022. Advances in Dietary Lipids and Human Health. Advances in Dietary Lipids and Human Health 251 271 .
Lei Ying, Luyao Wang, Kaiwen Guo, Yushu Hou, Na Li, Shuyi Wang, Xingfeng Liu, Qijin Zhao, Jie Zhou, Longwei Zhao, Jianlou Niu, Chuchu Chen, Lintao Song, Shaocong Hou, Lijuan Kong, Xiaokun Li, Jun Ren, Pingping Li, Moosa Mohammadi & Zhifeng Huang. (2021) Paracrine FGFs target skeletal muscle to exert potent anti-hyperglycemic effects. Nature Communications 12:1.
Crossref
Fu-Shun Yen, James Cheng-Chung Wei, Yu-Cih Yang, Chih-Cheng Hsu & Chii-Min Hwu. (2021) Thiazolidinedione Use in Individuals With Type 2 Diabetes and Chronic Obstructive Pulmonary Disease. Frontiers in Medicine 8.
Crossref
Yongkai Cao, Yuanquan Si, Meifen Li, Dahua Fan, Meiqun Cao, Seung Hoon Cheon, Jian Liang & Pei Lu. (2021) Licochalcone E improves insulin sensitivity in palmitic acid-treated HepG2 cells through inhibition of the NLRP3 signaling pathway. International Immunopharmacology 99, pages 107923.
Crossref
Qi Qin, Yan Chen, Yongbo Li, Jing Wei, Xiaoting Zhou, Fuyin Le, Hong Hu & Tingtao Chen. (2021) Intestinal Microbiota Play an Important Role in the Treatment of Type I Diabetes in Mice With BefA Protein. Frontiers in Cellular and Infection Microbiology 11.
Crossref
Silvia Speca, Caroline Dubuquoy, Christel Rousseaux, Philippe Chavatte, Pierre Desreumaux & Paolo Spagnolo. (2021) GED-0507 attenuates lung fibrosis by counteracting myofibroblast transdifferentiation in vivo and in vitro. PLOS ONE 16:9, pages e0257281.
Crossref
Li Feng, Shaoyong Lu, Zhen Zheng, Yingyi Chen, Yuanyuan Zhao, Kun Song, Hongjuan Xue, Lihua Jin, Yong Li, Cheng Huang, Yi-Ming Li & Jian Zhang. (2021) Identification of an allosteric hotspot for additive activation of PPARγ in antidiabetic effects. Science Bulletin 66:15, pages 1559-1570.
Crossref
Zhihan Wang, Xuefeng Yu & Yong Chen. (2021) Recruitment of Thermogenic Fat: Trigger of Fat Burning. Frontiers in Endocrinology 12.
Crossref
Longmin Chen, Jing Zhang, Yuan Zou, Faxi Wang, Jingyi Li, Fei Sun, Xi Luo, Meng Zhang, Yanchao Guo, Qilin Yu, Ping Yang, Qing Zhou, Zhishui Chen, Huilan Zhang, Quan Gong, Jiajun Zhao, Decio L. Eizirik, Zhiguang Zhou, Fei Xiong, Shu Zhang & Cong-Yi Wang. (2021) Kdm2a deficiency in macrophages enhances thermogenesis to protect mice against HFD-induced obesity by enhancing H3K36me2 at the Pparg locus. Cell Death & Differentiation 28:6, pages 1880-1899.
Crossref
S. R. Gilarevsky. (2021) Clinical Efficacy and Mechanisms of Actions of the Glucagon-Like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes Mellitus and High Risk of Cardiovascular Diseases. Kardiologiia 61:4, pages 66-72.
Crossref
Jonas Groner, Achim Goepferich & Miriam Breunig. (2021) Atherosclerosis: Conventional intake of cardiovascular drugs versus delivery using nanotechnology – A new chance for causative therapy?. Journal of Controlled Release 333, pages 536-559.
Crossref
Parcival Maissan, Eva Mooij & Matteo Barberis. (2021) Sirtuins-Mediated System-Level Regulation of Mammalian Tissues at the Interface between Metabolism and Cell Cycle: A Systematic Review. Biology 10:3, pages 194.
Crossref
Bidyut Mallick, Ashish Ranjan Sharma, Manojit Bhattacharya, Sang-Soo Lee & Chiranjib Chakraborty. (2021) PPARγ LBD and its ligand specificity reveal a selection of potential partial agonist: Molecular dynamics based T2D drug discovery initiative. BIOCELL 45:4, pages 953-961.
Crossref
Fu‐Shun Yen, James Cheng‐Chung Wei, Lu‐Ting Chiu, Chih‐Cheng Hsu, Ming‐Chih Hou & Chii‐Min Hwu. (2020) Thiazolidinediones were associated with higher risk of cardiovascular events in patients with type 2 diabetes and cirrhosis. Liver International 41:1, pages 110-122.
Crossref
Franck Peiretti, Roberta Montanari, Davide Capelli, Bernadette Bonardo, Cécilia Colson, Ez-Zoubir Amri, Marina Grimaldi, Patrick Balaguer, Keiichi Ito, Robert G. Roeder, Giorgio Pochetti & Jean Michel Brunel. (2020) A Novel N-Substituted Valine Derivative with Unique Peroxisome Proliferator-Activated Receptor γ Binding Properties and Biological Activities. Journal of Medicinal Chemistry 63:21, pages 13124-13139.
Crossref
Yanan Song, Haiyan Wang, Lingling Qin, Mei Li, Saiyue Gao, Lili Wu & Tonghua Liu. (2020) Efficiency and Safety of Chinese Herbal Medicine in the Treatment of Prediabetes: A Systemic Review and Meta-Analysis of Randomized Controlled Trials. Evidence-Based Complementary and Alternative Medicine 2020, pages 1-16.
Crossref
Nazanin Momeni Roudsari, Naser-Aldin Lashgari, Nadia Zandi, Benyamin Pazoki, Saeideh Momtaz, Amirhossein Sahebkar & Amir Hossein Abdolghaffari. (2020) PPARγ: A turning point for irritable bowel syndrome treatment. Life Sciences 257, pages 118103.
Crossref
Gabriel Xavier Ramalho & Marcio Garrison Dytz. (2020) Diabetes of the Exocrine Pancreas Related to Hereditary Pancreatitis, an Update. Current Diabetes Reports 20:6.
Crossref
Ruping Pan, Xiaohua Zhu, Pema Maretich & Yong Chen. (2020) Combating Obesity With Thermogenic Fat: Current Challenges and Advancements. Frontiers in Endocrinology 11.
Crossref
Fei Wang, Renfei Luo, Chang-Jiang Zou, Shiying Xie, Kexin Peng, Long Zhao, Kevin T. Yang, Chuanming Xu & Tianxin Yang. (2020) Soluble (pro)renin receptor treats metabolic syndrome in mice with diet-induced obesity via interaction with PPARγ. JCI Insight 5:7.
Crossref
Sydney L. Lane, Alexandrea S. Doyle, Elise S. Bales, Julie A. Houck, Ramón A. Lorca, Lorna G. Moore & Colleen G. Julian. (2020) Peroxisome proliferator‐activated receptor gamma blunts endothelin‐1‐mediated contraction of the uterine artery in a murine model of high‐altitude pregnancy. The FASEB Journal 34:3, pages 4283-4292.
Crossref
Jian Dai, Bo Ji, Guozhen Zhao, Yawen Lu, Yitian Liu, Qiujie Mou, Reiko Sakurai, Yana Xie, Qin Zhang, Shuang Xu & Virender K. Rehan. (2020) Developmental Timing Determines the Protective Effect of Maternal Electroacupuncture on Perinatal Nicotine Exposure-Induced Offspring Lung Phenotype. BioMed Research International 2020, pages 1-10.
Crossref
Yuhua Ma, Manman Shi, Yuxin Wang & Jian Liu. (2020) PPAR γ and Its Agonists in Chronic Kidney Disease . International Journal of Nephrology 2020, pages 1-10.
Crossref
Xunshan Ding, Rugmani Iyer, Christopher Novotny, Daniel Metzger, Heather H. Zhou, Gordon I. Smith, Mihoko Yoshino, Jun Yoshino, Samuel Klein, Gayathri Swaminath, Saswata Talukdar & Yingjiang Zhou. (2020) Inhibition of Grb14, a negative modulator of insulin signaling, improves glucose homeostasis without causing cardiac dysfunction. Scientific Reports 10:1.
Crossref
Lin Yu, Hequn Li, Chi Zhang, Qiang Zhang, Jiabin Guo, Jin Li, Haitao Yuan, Lizhong Li, Paul Carmichael & Shuangqing Peng. (2020) Integrating in vitro testing and physiologically-based pharmacokinetic (PBPK) modelling for chemical liver toxicity assessment—A case study of troglitazone. Environmental Toxicology and Pharmacology 74, pages 103296.
Crossref
Liwen Zhang, Ying Zhou, Fangfang Zhou, Xialian Yu, Jian Liu, Yunzi Liu, Yufei Zhu, Weiming Wang & Nan Chen. (2020) Altered Expression of Long Noncoding and Messenger RNAs in Diabetic Nephropathy following Treatment with Rosiglitazone. BioMed Research International 2020, pages 1-17.
Crossref
Mark Yates, Katie Bechman & James Galloway. (2020) The use of real-world data to address questions of patient safety. Rheumatology 59:1, pages 26-30.
Crossref
Stefanie Wittrisch, Nora Klöting, Karin Mörl, Rima Chakaroun, Matthias Blüher & Annette G. Beck-Sickinger. (2020) NPY1R-targeted peptide-mediated delivery of a dual PPARα/γ agonist to adipocytes enhances adipogenesis and prevents diabetes progression. Molecular Metabolism 31, pages 163-180.
Crossref
Juan Zheng, Ting Chen, Xin Guo, James M. Ntambi & Chaodong Wu. 2020. Lipid Signaling and Metabolism. Lipid Signaling and Metabolism 273 295 .
Victor Hernandez-Olmos, Tilo Knape, Jan Heering, Andreas von Knethen, Whitney Kilu, Astrid Kaiser, Mario Wurglics, Moritz Helmstädter, Daniel Merk, Manfred Schubert-Zsilavecz, Michael J. Parnham, Dieter Steinhilber & Ewgenij Proschak. (2019) Structure optimization of a new class of PPARγ antagonists. Bioorganic & Medicinal Chemistry 27:21, pages 115082.
Crossref
Subrat Kumar Bhattamisra, Tiew Chin Siang, Chieng Yi Rong, Naveenya Chetty Annan, Esther Ho Yung Sean, Lim Wen Xi, Ong Siu Lyn, Liew Hui Shan, Hira Choudhury, Manisha Pandey & Bapi Gorain. (2019) Type-3c Diabetes Mellitus, Diabetes of Exocrine Pancreas - An Update. Current Diabetes Reviews 15:5, pages 382-394.
Crossref
Sydney L. Lane, R. Blair Dodson, Alexandrea S. Doyle, Haemin Park, Hinal Rathi, Christopher J. Matarrazo, Lorna G. Moore, Ramón A. Lorca, Gabriel H. Wolfson & Colleen G. Julian. (2019) Pharmacological activation of peroxisome proliferator‐activated receptor γ (PPAR‐γ) protects against hypoxia‐associated fetal growth restriction. The FASEB Journal 33:8, pages 8999-9007.
Crossref
Jungbin Song, Young-Sik Kim, Dong Hwan Lee, Sung Hyun Lee, Hyo Jin Park, Donghun Lee & Hocheol Kim. (2019) Neuroprotective effects of oleic acid in rodent models of cerebral ischaemia. Scientific Reports 9:1.
Crossref
Ni Gao, Xiaofeng Yao, Liping Jiang, Lei Yang, Tianming Qiu, Zhidong Wang, Pei Pei, Guang Yang, Xiaofang Liu & Xiance Sun. (2018) Taurine improves low‐level inorganic arsenic‐induced insulin resistance by activating PPARγ‐mTORC2 signalling and inhibiting hepatic autophagy. Journal of Cellular Physiology 234:4, pages 5143-5152.
Crossref
Sant Kumar Verma, Yatesh Sharad Yadav & Suresh Thareja. (2019) 2,4-Thiazolidinediones as PTP 1B Inhibitors: A Mini Review (2012-2018). Mini-Reviews in Medicinal Chemistry 19:7, pages 591-598.
Crossref
Yuhui Wang, Xiyang Zhang, Bo Yuan, Xi Lu, Dongxuan Zheng, Kefeng Zhang, Mingli Zhong, Xiaotian Xu & Xiaoqun Duan. (2019) GVS-12 attenuates non-alcoholic steatohepatitis by suppressing inflammatory responses via PPARγ/STAT3 signaling pathways . RSC Advances 9:17, pages 9555-9564.
Crossref
Taro E. Akiyama, Graham E. Skelhorne-Gross, Elizabeth D. Lightbody, Rachel E. Rubino, Jia Yue Shi, Lesley A. McNamara, Neelam Sharma, Emanuel I. Zycband, Frank J. Gonzalez, Haiying Liu, John W. Woods, C. H. Chang, Joel P. Berger & Christopher J. B. Nicol. (2019) Endothelial Cell–Targeted Deletion of PPAR γ Blocks Rosiglitazone-Induced Plasma Volume Expansion and Vascular Remodeling in Adipose Tissue . Journal of Pharmacology and Experimental Therapeutics 368:3, pages 514-523.
Crossref
Daejin Kim, Byul-Nim Ahn, YeongSeok Kim, Dae Young Hur, Jae Wook Yang, Ga Bin Park, Jung Eun Jang, Eun Ju Lee, Min Jeong Kwon, Tae Nyun Kim, Mi Kyung Kim, Jeong Hyun Park, Byoung Doo Rhee & Soon Hee Lee. (2019) High Glucose with Insulin Induces Cell Cycle Progression and Activation of Oncogenic Signaling of Bladder Epithelial Cells Cotreated with Metformin and Pioglitazone. Journal of Diabetes Research 2019, pages 1-10.
Crossref
Shian-Ren Lin, Chia-Hsiang Chang, May-Jwan Tsai, Henrich Cheng, Jian-Chyi Chen, Max K. Leong & Ching-Feng Weng. (2019) The perceptions of natural compounds against dipeptidyl peptidase 4 in diabetes: from in silico to in vivo . Therapeutic Advances in Chronic Disease 10, pages 204062231987530.
Crossref
Jingchao Liu, Zhangjian Huang, Wenhuan Ma, Sixun Peng, Yunman Li, Katrina M. Miranda, Jide Tian & Yihua Zhang. (2019) Design and synthesis of rosiglitazone-ferulic acid-nitric oxide donor trihybrids for improving glucose tolerance. European Journal of Medicinal Chemistry 162, pages 650-665.
Crossref
Fengli Li, Weiguang Sun, Jiankun Guan, Yuanyuan Lu, Sitian Zhang, Shuang Lin, Junjun Liu, Weixi Gao, Jianping Wang, Zhengxi Hu & Yonghui Zhang. (2018) Alterbrassicicene A, a Highly Transformed Fusicoccane-Derived Diterpenoid with Potent PPAR-γ Agonistic Activity from Alternaria brassicicola . Organic Letters 20:24, pages 7982-7986.
Crossref
Karolina Łagowska, Joanna Bajerska & Małgorzata Jamka. (2018) The Role of Vitamin D Oral Supplementation in Insulin Resistance in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Nutrients 10:11, pages 1637.
Crossref
Jie Zheng, Cesar Corzo, Mi Ra Chang, Jinsai Shang, Vinh Q. Lam, Richard Brust, Anne-Laure Blayo, John B. Bruning, Theodore M. Kamenecka, Douglas J. Kojetin & Patrick R. Griffin. (2018) Chemical Crosslinking Mass Spectrometry Reveals the Conformational Landscape of the Activation Helix of PPARγ; a Model for Ligand-Dependent Antagonism. Structure 26:11, pages 1431-1439.e6.
Crossref
Junjun Shen, Tao Yang, Youzhi Xu, Yi Luo, Xinyue Zhong, Limin Shi, Tao Hu, Tianyi Guo, Ying Nie, Feijun Luo & Qinlu Lin. (2018) δ-Tocotrienol, Isolated from Rice Bran, Exerts an Anti-Inflammatory Effect via MAPKs and PPARs Signaling Pathways in Lipopolysaccharide-Stimulated Macrophages. International Journal of Molecular Sciences 19:10, pages 3022.
Crossref
Susan Westfall, Nikita Lomis & Satya Prakash. (2018) A polyphenol-rich prebiotic in combination with a novel probiotic formulation alleviates markers of obesity and diabetes in Drosophila. Journal of Functional Foods 48, pages 374-386.
Crossref
Reuben L Smith, Maarten R Soeters, Rob C I Wüst & Riekelt H Houtkooper. (2018) Metabolic Flexibility as an Adaptation to Energy Resources and Requirements in Health and Disease. Endocrine Reviews 39:4, pages 489-517.
Crossref
Patricia Corrales, Antonio Vidal-Puig & Gema Medina-Gómez. (2018) PPARs and Metabolic Disorders Associated with Challenged Adipose Tissue Plasticity. International Journal of Molecular Sciences 19:7, pages 2124.
Crossref
Patricia Corrales, Adriana Izquierdo-Lahuerta & Gema Medina-Gómez. (2018) Maintenance of Kidney Metabolic Homeostasis by PPAR Gamma. International Journal of Molecular Sciences 19:7, pages 2063.
Crossref
Anaïs BriotPauline DecaunesFanny VolatChloé BellesMuriel CoupayeSéverine LedouxAnne Bouloumié. (2018) Senescence Alters PPARγ (Peroxisome Proliferator–Activated Receptor Gamma)-Dependent Fatty Acid Handling in Human Adipose Tissue Microvascular Endothelial Cells and Favors Inflammation. Arteriosclerosis, Thrombosis, and Vascular Biology 38:5, pages 1134-1146.
Crossref
Vincenzo SorrentinoKeir J. MenziesJohan Auwerx. (2018) Repairing Mitochondrial Dysfunction in Disease. Annual Review of Pharmacology and Toxicology 58:1, pages 353-389.
Crossref
Vanessa Castelli, Michele d'Angelo, Andrea Antonosante, Mariano Catanesi, Elisabetta Benedetti, Giovambattista Desideri & Annamaria Cimini. (2018) Physiology and Pathophysiology of PPARs in the Eye. Nuclear Receptor Research 5.
Crossref
Roberto Trevisan. (2017) The Role of Vildagliptin in the Therapy of Type 2 Diabetic Patients with Renal Dysfunction. Diabetes Therapy 8:6, pages 1215-1226.
Crossref
Reza Yekta, Gholamreza Dehghan, Samaneh Rashtbari, Nader Sheibani & Ali Akbar Moosavi-Movahedi. (2017) Activation of catalase by pioglitazone: Multiple spectroscopic methods combined with molecular docking studies. Journal of Molecular Recognition 30:12, pages e2648.
Crossref
Dmytro Kukhtar, Miquel Mulero, Raul Beltrán‐Debón, Cristina Valls, Gerard Pujadas & Santiago Garcia‐Vallve. 2017. Drug Selectivity. Drug Selectivity 397 432 .
Yoojin Noh, Dae Ryong Kang, Dae Jung Kim, Kwang Jae Lee, Sukhyang Lee & Sooyoung Shin. (2017) Impact of clinical evidence communications and drug regulation changes concerning rosiglitazone on prescribing patterns of antidiabetic therapies. Pharmacoepidemiology and Drug Safety 26:11, pages 1338-1346.
Crossref
Celine Pirat, Catherine Dacquet, Veronique Leclerc, Nathalie Hennuyer, Monique Beucher-Gaudin, Ghislaine Zanirato, Anne Géant, Bart Staels, Alain Ktorza, Amaury Farce, Daniel-Henri Caignard, Pascal Berthelot & Nicolas Lebegue. (2017) Anti-diabetic activity of fused PPARγ-SIRT1 ligands with limited body-weight gain by mimicking calorie restriction and decreasing SGK1 expression. European Journal of Medicinal Chemistry 137, pages 310-326.
Crossref
Baskaran Thyagarajan & Michelle T. Foster. (2017) Beiging of white adipose tissue as a therapeutic strategy for weight loss in humans. Hormone Molecular Biology and Clinical Investigation 31:2.
Crossref
Funda Datli Yakaryılmaz & Zeynel Abidin Öztürk. (2017) Treatment of type 2 diabetes mellitus in the elderly. World Journal of Diabetes 8:6, pages 278.
Crossref
Mi-Jeong Oh, Hyun-Ju Kim, Eun-Young Park, Na-Hee Ha, Mun-Gyu Song, Sang-Hyun Choi, Boe-Gwun Chun & Dong-Hoon Kim. (2017) The effect of Korean Red Ginseng extract on rosiglitazone-induced improvement of glucose regulation in diet-induced obese mice. Journal of Ginseng Research 41:1, pages 52-59.
Crossref
Soumik Agarwal, Mrittika Chattopadhyay, Sandip Mukherjee, Suman Dasgupta, Satinath Mukhopadhyay & Samir Bhattacharya. (2017) Fetuin-A downregulates adiponectin through Wnt-PPARγ pathway in lipid induced inflamed adipocyte. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1863:1, pages 174-181.
Crossref
Chantal Bolduc, Leonard C. Sperling & Jerry Shapiro. (2016) Primary cicatricial alopecia. Journal of the American Academy of Dermatology 75:6, pages 1081-1099.
Crossref
Pablo Yang, Verónica Ojeda Heredia, Dante M. Beltramo & Néstor W. Soria. (2016) Pharmacogenetics and personalized treatment of type 2 diabetes mellitus. International Journal of Diabetes in Developing Countries 36:4, pages 508-518.
Crossref
E Kristóf, Q-M Doan-Xuan, A K Sárvári, Á Klusóczki, P Fischer-Posovszky, M Wabitsch, Z Bacso, P Bai, Z Balajthy & L Fésüs. (2016) Clozapine modifies the differentiation program of human adipocytes inducing browning. Translational Psychiatry 6:11, pages e963-e963.
Crossref
Xi Fang, Matthew J. Stroud, Kunfu Ouyang, Li Fang, Jianlin Zhang, Nancy D. Dalton, Yusu Gu, Tongbin Wu, Kirk L. Peterson, Hsien-Da Huang, Ju Chen & Nanping Wang. (2016) Adipocyte-specific loss of PPARγ attenuates cardiac hypertrophy. JCI Insight 1:16.
Crossref
M.J. Meneses, R.L. Bernardino, R. Sá, J. Silva, A. Barros, M. Sousa, B.M. Silva, P.F. Oliveira & M.G. Alves. (2016) Pioglitazone increases the glycolytic efficiency of human Sertoli cells with possible implications for spermatogenesis. The International Journal of Biochemistry & Cell Biology 79, pages 52-60.
Crossref
Isabelle Mothe-Satney, Joseph Murdaca, Brigitte Sibille, Anne-Sophie Rousseau, Raphaëlle Squillace, Gwenaëlle Le Menn, Akila Rekima, Frederic Larbret, Juline Pelé, Valérie Verhasselt, Paul A. Grimaldi & Jaap G. Neels. (2016) A role for Peroxisome Proliferator-Activated Receptor Beta in T cell development. Scientific Reports 6:1.
Crossref
Attila Pap, Ixchelt Cuaranta-Monroy, Matthew Peloquin & Laszlo Nagy. (2016) Is the Mouse a Good Model of Human PPARγ-Related Metabolic Diseases?. International Journal of Molecular Sciences 17:8, pages 1236.
Crossref
Liang Ma, Tzu-Wen Liu, Matthew A. Wallig, Iwona T. Dobrucki, Lawrence W. Dobrucki, Erik R. Nelson, Kelly S. Swanson & Andrew M. Smith. (2016) Efficient Targeting of Adipose Tissue Macrophages in Obesity with Polysaccharide Nanocarriers. ACS Nano 10:7, pages 6952-6962.
Crossref
Marie-Louise Zeissler, Jordan Eastwood, Kieran McCorry, C. Oliver Hanemann, John P. Zajicek & Camille B. Carroll. (2016) Delta-9-tetrahydrocannabinol protects against MPP+ toxicity in SH-SY5Y cells by restoring proteins involved in mitochondrial biogenesis. Oncotarget 7:29, pages 46603-46614.
Crossref
Jaspreet Singh, Brittany Olle, Hamid Suhail, Michelle M. Felicella & Shailendra Giri. (2016) Metformin-induced mitochondrial function and ABCD2 up-regulation in X-linked adrenoleukodystrophy involves AMP-activated protein kinase. Journal of Neurochemistry 138:1, pages 86-100.
Crossref
Nina ProkophMats OrmöGavin O'MahonyAnders HognerJane McPheatUlla KarlssonLovisa Holmberg SchiavoneJianming Liu. (2016) Development of an ELISA for High-Throughput Screening of Inhibitors of Cdk5-Mediated PPARγ Phosphorylation. ASSAY and Drug Development Technologies 14:4, pages 261-272.
Crossref
Markolf Hanefeld, Frank Pistrosch, Stefan R. Bornstein & Andreas L. Birkenfeld. (2016) The metabolic vascular syndrome - guide to an individualized treatment. Reviews in Endocrine and Metabolic Disorders 17:1, pages 5-17.
Crossref
Wei Huang, Peter Szatmary, Meihua Wan, Shameena Bharucha, Muhammad Awais, Wenfu Tang, David N. Criddle, Qing Xia & Robert Sutton. (2016) Translational Insights Into Peroxisome Proliferator-Activated Receptors in Experimental Acute Pancreatitis. Pancreas 45:2, pages 167-178.
Crossref
Julio WainsteinZohar LandauYosefa Bar DayanDaniela JakubowiczTorsten GrotheTania Perrinjaquet-MoccettiMona Boaz. (2016) Purslane Extract and Glucose Homeostasis in Adults with Type 2 Diabetes: A Double-Blind, Placebo-Controlled Clinical Trial of Efficacy and Safety. Journal of Medicinal Food 19:2, pages 133-140.
Crossref
David R. Matthews. 2016. Advanced Nutrition and Dietetics in Diabetes. Advanced Nutrition and Dietetics in Diabetes 93 102 .
Masashi Mukohda, Madeliene Stump, Pimonrat Ketsawatsomkron, Chunyan Hu, Frederick W. Quelle & Curt D. Sigmund. (2016) Endothelial PPAR-γ provides vascular protection from IL-1β-induced oxidative stress. American Journal of Physiology-Heart and Circulatory Physiology 310:1, pages H39-H48.
Crossref
Michael Brownlee, Lloyd P. Aiello, Mark E. Cooper, Aaron I. Vinik, Jorge Plutzky & Andrew J.M. Boulton. 2016. Williams Textbook of Endocrinology. Williams Textbook of Endocrinology 1484 1581 .
Susanne Rohrbach & Bernd Niemann. 2016. Cardiomyocytes – Active Players in Cardiac Disease. Cardiomyocytes – Active Players in Cardiac Disease 97 134 .
Jennifer M. Kleinhenz, Tamara C. Murphy, Anastassia P. Pokutta-Paskaleva, Rudolph L. Gleason, Alicia N. Lyle, W. Robert Taylor, Mitsi A. Blount, Juan Cheng, Qinglin Yang, Roy L. Sutliff & C. Michael Hart. (2015) Smooth Muscle-Targeted Overexpression of Peroxisome Proliferator Activated Receptor-γ Disrupts Vascular Wall Structure and Function. PLOS ONE 10:10, pages e0139756.
Crossref
Alyssa M. Keil, Douglas M. Frederick, Erina Y. Jacinto, Erica L. Kennedy, Randy J. Zauhar, Nathan M. West, Ruy Tchao & Peter J. Harvison. (2015) Cytotoxicity of thiazolidinedione-, oxazolidinedione- and pyrrolidinedione-ring containing compounds in HepG2 cells. Toxicology in Vitro 29:7, pages 1887-1896.
Crossref
Alice Asteian, Anne-Laure Blayo, Yuanjun He, Marcel Koenig, Youseung Shin, Dana S. Kuruvilla, Cesar A. Corzo, Michael D. Cameron, Li Lin, Claudia Ruiz, Susan Khan, Naresh Kumar, Scott Busby, David P. Marciano, Ruben D. Garcia-Ordonez, Patrick R. Griffin & Theodore M. Kamenecka. (2015) Design, Synthesis, and Biological Evaluation of Indole Biphenylcarboxylic Acids as PPARγ Antagonists. ACS Medicinal Chemistry Letters 6:9, pages 998-1003.
Crossref
H Yokoyama, S Araki, K Kawai, K Hirao, M Oishi, K Sugimoto, H Sone, H Maegawa & A Kashiwagi. (2015) Pioglitazone treatment and cardiovascular event and death in subjects with type 2 diabetes without established cardiovascular disease (JDDM 36). Diabetes Research and Clinical Practice 109:3, pages 485-492.
Crossref
Elizabeth E. Roughead, Esther W. Chan, Nam-Kyong Choi, Michio Kimura, Tomomi Kimura, Kiyoshi Kubota, Edward Chia-Cheng Lai, Kenneth K. C. Man, Tuan Anh Nguyen, Nobuhiro Ooba, Byung-Joo Park, Tsugumichi Sato, Ju-Young Shin, TongTong Wang, Jenna Griffiths, Ian C. K. Wong, Yea-Huei Kao Yang & Nicole L. Pratt. (2015) Variation in Association Between Thiazolidinediones and Heart Failure Across Ethnic Groups: Retrospective analysis of Large Healthcare Claims Databases in Six Countries. Drug Safety 38:9, pages 823-831.
Crossref
Jing Yao, WeiJia Kong & JianDong Jiang. (2014) Learning from berberine: Treating chronic diseases through multiple targets. Science China Life Sciences 58:9, pages 854-859.
Crossref
Fernanda A. César, Martina Rudnicki, Beatriz de las Heras, Lisardo Boscá, Maria C.A. Lima, Ivan R. Pitta & Dulcineia S.P. Abdalla. (2015) New indole-thiazolidine attenuates atherosclerosis in LDLr−/− mice. Vascular Pharmacology 71, pages 174-180.
Crossref
Avivit Cahn, Roberto Miccoli, Angela Dardano & Stefano Del Prato. (2015) New forms of insulin and insulin therapies for the treatment of type 2 diabetes. The Lancet Diabetes & Endocrinology 3:8, pages 638-652.
Crossref
Siavash Babajafari, Farzad Nikaein, Seyed Mohammad Mazloomi, Mohammad Javad Zibaeenejad & Arman Zargaran. (2015) A Review of the Benefits of Satureja Species on Metabolic Syndrome and Their Possible Mechanisms of Action . Journal of Evidence-Based Complementary & Alternative Medicine 20:3, pages 212-223.
Crossref
Ulrike Hostalek, Mike Gwilt & Steven Hildemann. (2015) Therapeutic Use of Metformin in Prediabetes and Diabetes Prevention. Drugs 75:10, pages 1071-1094.
Crossref
Vasyl HolobotovskyyYee Seng ChongJennifer BurchellBo HeMichael PhillipsLeo LeaderTimothy V. MurphyShaun L. SandowDouglas J. McKitrickAdrian K. CharlesMarianne TareLeonard F. ArnoldaRuth Ganss. (2015) Regulator of G protein signaling 5 is a determinant of gestational hypertension and preeclampsia. Science Translational Medicine 7:290.
Crossref
Juan Zheng, Shih-Lung Woo, Xiang Hu, Rachel Botchlett, Lulu Chen, Yuqing Huo & Chaodong Wu. (2015) Metformin and metabolic diseases: a focus on hepatic aspects. Frontiers of Medicine 9:2, pages 173-186.
Crossref
S. D. Goonesekera, M. H. Yang, S. A. Hall, S. C. Fang, R. S. Piccolo & J. B. McKinlay. (2015) Racial ethnic differences in type 2 diabetes treatment patterns and glycaemic control in the Boston Area Community Health Survey. BMJ Open 5:5, pages e007375-e007375.
Crossref
Yun-Xi Liu, Mei-Mei Si, Wei Lu, Li-Xia Zhang, Chang-Xin Zhou, Shu-Li Deng & Hao-Shu Wu. (2015) Effects and molecular mechanisms of the antidiabetic fraction of Acorus calamus L. on GLP-1 expression and secretion in vivo and in vitro. Journal of Ethnopharmacology 166, pages 168-175.
Crossref
Yuval Ramot, Arianna Mastrofrancesco, Emanuela Camera, Pierre Desreumaux, Ralf Paus & Mauro Picardo. (2015) The role of PPAR γ -mediated signalling in skin biology and pathology: new targets and opportunities for clinical dermatology . Experimental Dermatology 24:4, pages 245-251.
Crossref
Idris Harding, Derek M Yellon & Robert M Bell. (2015) Pharmacological cardioprotection in diabetes. Diabetes Management 5:2, pages 89-101.
Crossref
Die Gao, Yong-lan Zhang, Pan Xu, Ye-xin Lin, Feng-qing Yang, Jian-hui Liu, Hai-wen Zhu & Zhi-ning Xia. (2015) In vitro evaluation of dual agonists for PPARγ/β from the flower of Edgeworthia gardneri (wall.) Meisn. Journal of Ethnopharmacology 162, pages 14-19.
Crossref
Gaofeng Yuan, Xiaoe Chen & Duo Li. (2015) Modulation of Peroxisome Proliferator-Activated Receptor gamma (PPAR γ) by Conjugated Fatty Acid in Obesity and Inflammatory Bowel Disease. Journal of Agricultural and Food Chemistry 63:7, pages 1883-1895.
Crossref
Zhi-Xu He, Zhi-Wei Zhou, Yinxue Yang, Tianxin Yang, Si-Yuan Pan, Jia-Xuan Qiu & Shu-Feng Zhou. (2015) Overview of clinically approved oral antidiabetic agents for the treatment of type 2 diabetes mellitus. Clinical and Experimental Pharmacology and Physiology 42:2, pages 125-138.
Crossref
Sung-Hsun Yu, Szu-Yu Tina Chen, Wei-Shan Li, Navneet Kumar Dubey, Wei-Hong Chen, Jiunn-Jye Chuu, Sy-Jye Leu & Win-Ping Deng. (2015) Hypoglycemic Activity through a Novel Combination of Fruiting Body and Mycelia of Cordyceps militaris in High-Fat Diet-Induced Type 2 Diabetes Mellitus Mice . Journal of Diabetes Research 2015, pages 1-10.
Crossref
Su Zhang, Hongwei Gu & Nan Hu. (2015) Role of Peroxisome Proliferator-Activated Receptor γ in Ocular Diseases . Journal of Ophthalmology 2015, pages 1-10.
Crossref
Jihan Youssef & Mostafa Badr. (2015) Peroxisome Proliferator-Activated Receptors Features, Functions, and Future. Nuclear Receptor Research 2.
Crossref
David Della-Morte, Raffaele Palmirotta, Ashish K Rehni, Donatella Pastore, Barbara Capuani, Francesca Pacifici, Maria Laura De Marchis, Kunjan R Dave, Alfonso Bellia, Giuseppe Fogliame, Patrizia Ferroni, Giulia Donadel, Francesco Cacciatore, Pasquale Abete, Chuanhui Dong, Antonello Pileggi, Mario Roselli, Camillo Ricordi, Paolo Sbraccia, Fiorella Guadagni, Tatjana Rundek & Davide Lauro. (2014) Pharmacogenomics and pharmacogenetics of thiazolidinediones: role in diabetes and cardiovascular risk factors. Pharmacogenomics 15:16, pages 2063-2082.
Crossref
Lars Verschuren, Peter Y Wielinga, Thomas Kelder, Marijana Radonjic, Kanita Salic, Robert Kleemann, Ben van Ommen & Teake Kooistra. (2014) A systems biology approach to understand the pathophysiological mechanisms of cardiac pathological hypertrophy associated with rosiglitazone. BMC Medical Genomics 7:1.
Crossref
Sun-Sil Choi, Jiyoung Park & Jang Hyun Choi. (2014) Revisiting PPARγ as a target for the treatment of metabolic disorders. BMB Reports 47:11, pages 599-608.
Crossref
Daniel H. Kort & Roger A. Lobo. (2014) Preliminary evidence that cinnamon improves menstrual cyclicity in women with polycystic ovary syndrome: a randomized controlled trial. American Journal of Obstetrics and Gynecology 211:5, pages 487.e1-487.e6.
Crossref
E. Mennes, C. M. Dungan, S. Frendo-Cumbo, D. L. Williamson & D. C. Wright. (2013) Aging-Associated Reductions in Lipolytic and Mitochondrial Proteins in Mouse Adipose Tissue Are Not Rescued by Metformin Treatment. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 69:9, pages 1060-1068.
Crossref
Jaap G. Neels & Paul A. Grimaldi. (2014) Physiological Functions of Peroxisome Proliferator-Activated Receptor β. Physiological Reviews 94:3, pages 795-858.
Crossref
Sonia E. Step, Hee-Woong Lim, Jill M. Marinis, Andreas Prokesch, David J. Steger, Seo-Hee You, Kyoung-Jae Won & Mitchell A. Lazar. (2014) Anti-diabetic rosiglitazone remodels the adipocyte transcriptome by redistributing transcription to PPARγ-driven enhancers. Genes & Development 28:9, pages 1018-1028.
Crossref
Juan Wang, Tao Pang, Roman Hafko, Julius Benicky, Enrique Sanchez-Lemus & Juan M. Saavedra. (2014) Telmisartan ameliorates glutamate-induced neurotoxicity: Roles of AT1 receptor blockade and PPARγ activation. Neuropharmacology 79, pages 249-261.
Crossref
Arie Ben Yehuda, Adar Zinger & Samuel Durso. (2014) The older patient with diabetes: a practical approach. Diabetes/Metabolism Research and Reviews 30:2, pages 88-95.
Crossref
Sara Heebøll. (2014) Effects of resveratrol in experimental and clinical non-alcoholic fatty liver disease. World Journal of Hepatology 6:4, pages 188.
Crossref
Zhanjun Jia, Ying Sun, Guangrui Yang, Aihua Zhang, Songming Huang, Kristina Marie Heiney & Yue Zhang. (2014) New Insights into the PPAR γ Agonists for the Treatment of Diabetic Nephropathy . PPAR Research 2014, pages 1-7.
Crossref
Lucie Cahlíková, Kateřina Macáková, Nina Benešová, Jakub Chlebek, Anna Hošťálková & Lubomír Opletal. 2014. 153 194 .
Sarah D. Corathers, Shawn Peavie & Marzieh Salehi. (2013) Complications of Diabetes Therapy. Endocrinology and Metabolism Clinics of North America 42:4, pages 947-970.
Crossref
Li ZhouGang LiuZhanjun JiaKevin T. YangYing SunYutaka KakizoeMi LiuShufeng Zhou, Ren Chen, Baoxue YangTianxin Yang. (2013) Increased susceptibility of db/db mice to rosiglitazone-induced plasma volume expansion: role of dysregulation of renal water transporters . American Journal of Physiology-Renal Physiology 305:10, pages F1491-F1497.
Crossref
Robert Wolfgang Schwenk, Heike Vogel & Annette Schürmann. (2013) Genetic and epigenetic control of metabolic health. Molecular Metabolism 2:4, pages 337-347.
Crossref
Guntram Schernthaner, Craig J. CurrieGerit-Holger Schernthaner. (2013) Do We Still Need Pioglitazone for the Treatment of Type 2 Diabetes? A risk-benefit critique in 2013. Diabetes Care 36:Supplement_2, pages S155-S161.
Crossref
Michael R. Rickels, Melena Bellin, Frederico G.S. Toledo, R. Paul Robertson, Dana K. Andersen, Suresh T. Chari, Randall Brand, Luca Frulloni, Michelle A. Anderson & David C. Whitcomb. (2013) Detection, evaluation and treatment of diabetes mellitus in chronic pancreatitis: Recommendations from PancreasFest 2012. Pancreatology 13:4, pages 336-342.
Crossref
Omar Sharif, Ulrich Matt, Simona Saluzzo, Karin Lakovits, Isabella Haslinger, Tanja Furtner, Bianca Doninger & Sylvia Knapp. (2013) The Scavenger Receptor CD36 Downmodulates the Early Inflammatory Response while Enhancing Bacterial Phagocytosis during Pneumococcal Pneumonia. The Journal of Immunology 190:11, pages 5640-5648.
Crossref
Pénélope A. Andreux, Riekelt H. Houtkooper & Johan Auwerx. (2013) Pharmacological approaches to restore mitochondrial function. Nature Reviews Drug Discovery 12:6, pages 465-483.
Crossref
Jianming Liu, Mats Ormö, Ann-Christin Nyström, Josefine Claesson & Fabrizio Giordanetto. (2013) Transient expression, purification and characterisation of human full-length PPARγ2 in HEK293 cells. Protein Expression and Purification 89:2, pages 189-195.
Crossref
Maryam Ahmadian, Jae Myoung Suh, Nasun Hah, Christopher Liddle, Annette R Atkins, Michael Downes & Ronald M Evans. (2013) PPARγ signaling and metabolism: the good, the bad and the future. Nature Medicine 19:5, pages 557-566.
Crossref
Fergus P McCarthy, Aoife C Delany, Louise C Kenny & Sarah K Walsh. (2013) PPAR-γ - a possible drug target for complicated pregnancies. British Journal of Pharmacology 168:5, pages 1074-1085.
Crossref
George Grunberger. (2013) Will PPAR-γ agonist therapy still have a role in diabetes management in 2013?. Diabetes Management 3:1, pages 41-51.
Crossref
Jerzy Bełtowski, Jolanta Rachańczyk & Mirosław Włodarczyk. (2013) Thiazolidinedione-Induced Fluid Retention: Recent Insights into the Molecular Mechanisms. PPAR Research 2013, pages 1-8.
Crossref
Janosch Achenbach, Matthias Gabler, Ramona Steri, Manfred Schubert-Zsilavecz & Ewgenij Proschak. (2013) Identification of novel farnesoid X receptor modulators using a combined ligand- and structure-based virtual screening. MedChemComm 4:6, pages 920.
Crossref
Jihan A. Youssef & Mostafa Z. BadrJihan A. Youssef & Mostafa Z. Badr. 2013. Peroxisome Proliferator-Activated Receptors. Peroxisome Proliferator-Activated Receptors 87 90 .
Jihan A. Youssef & Mostafa Z. BadrJihan A. Youssef & Mostafa Z. Badr. 2013. Peroxisome Proliferator-Activated Receptors. Peroxisome Proliferator-Activated Receptors 33 69 .
Dirk A. Ridder & Markus Schwaninger. (2012) In search of the neuroprotective mechanism of thiazolidinediones in Parkinson's disease. Experimental Neurology 238:2, pages 133-137.
Crossref
André J. Scheen. (2012) Outcomes and lessons from the PROactive study. Diabetes Research and Clinical Practice 98:2, pages 175-186.
Crossref
Paul Norwood, Joanne F. Liutkus, Harry Haber, Ella Pintilei, Marilyn K. Boardman & Michael E. Trautmann. (2012) Safety of Exenatide Once Weekly in Patients With Type 2 Diabetes Mellitus Treated With a Thiazolidinedione Alone or in Combination With Metformin for 2 Years. Clinical Therapeutics 34:10, pages 2082-2090.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.